A team of researchers has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal program/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer ...
Jan 30, 2024
0
0
Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large ...
Jan 29, 2024
0
0
For patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) improves progression-free survival (PFS), ...
Jan 29, 2024
0
0
Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening program are around four times as likely to develop invasive breast cancer and to die from breast cancer than women in the general ...
Jan 24, 2024
0
7
A new research paper titled "Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis" has been published in Aging.
Jan 24, 2024
0
0
Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.
Jan 20, 2024
0
28
Relatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according to a study published in the February issue of Cancer ...
Jan 19, 2024
0
0
The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration.
Jan 18, 2024
0
0
About 100 cancer predisposition genes (CPGs) are known. The probability of developing cancer is greater in individuals who inherit certain altered variants of one of these genes.
Jan 16, 2024
0
0
An international clinical trial of a treatment for advanced urothelial cancer has found a new dual therapy can nearly double patients' life expectancy.
Jan 9, 2024
0
0
